{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T22:45:45Z","timestamp":1774824345157,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1D1AB03028590"],"award-info":[{"award-number":["2017R1D1AB03028590"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00252326"],"award-info":[{"award-number":["RS-2023-00252326"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2024-00512909"],"award-info":[{"award-number":["RS-2024-00512909"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002582","name":"Gwangju Institute of Science and Technology","doi-asserted-by":"publisher","award":["Future-Leading Specialized Research Project, 2025"],"award-info":[{"award-number":["Future-Leading Specialized Research Project, 2025"]}],"id":[{"id":"10.13039\/501100002582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002582","name":"Gwangju Institute of Science and Technology","doi-asserted-by":"publisher","award":["GRI IIBR grant"],"award-info":[{"award-number":["GRI IIBR grant"]}],"id":[{"id":"10.13039\/501100002582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,4,18]]},"DOI":"10.1038\/s41388-026-03717-9","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T05:33:23Z","timestamp":1773034403000},"page":"1234-1246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cereblon (CRBN) inhibits prostate cancer metastasis by negatively regulating 6-phosphogluconate dehydrogenase (6PGD)"],"prefix":"10.1038","volume":"45","author":[{"given":"Koushik","family":"Guchhait","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon-Seung","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Su","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungheon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Seung","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco D.","family":"Yanqui-Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samara M.","family":"O\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1.","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Yeon","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2824-490X","authenticated-orcid":false,"given":"Daeho","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul-Seung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee-Young","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doo Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3932-995X","authenticated-orcid":false,"given":"Seokjae","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Geun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8547-8430","authenticated-orcid":false,"given":"Steve K.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"3717_CR1","doi-asserted-by":"crossref","unstructured":"Mucci LA, Wilson KM, Giovannucci EL. Epidemiology of prostate cancer. In: Pathology and Epidemiology of Cancer. Cham: Springer International Publishing; 2016. 107\u201325.","DOI":"10.1007\/978-3-319-35153-7_9"},{"key":"3717_CR2","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149:778\u201389.","journal-title":"Int J Cancer"},{"key":"3717_CR3","doi-asserted-by":"publisher","first-page":"e2119568","DOI":"10.1001\/jamanetworkopen.2021.19568","volume":"4","author":"AO Elmehrath","year":"2021","unstructured":"Elmehrath AO, Afifi AM, Al-Husseini MJ, Saad AM, Wilson N, Shohdy KS, et al. Causes of death among patients with metastatic prostate cancer in the US from 2000 to 2016. JAMA Netw Open. 2021;4:e2119568.","journal-title":"JAMA Netw Open"},{"key":"3717_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5:28.","journal-title":"Signal Transduct Target Ther"},{"key":"3717_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.5230\/jgc.2014.14.4.271","volume":"14","author":"AM Soe","year":"2014","unstructured":"Soe AM, Bordia S, Xiao PQ, Lopez-Morra H, Tejada J, Atluri S, et al. A rare presentation of metastasis of prostate adenocarcinoma to the stomach and rectum. J Gastric Cancer. 2014;14:271\u20134.","journal-title":"J Gastric Cancer"},{"key":"3717_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00424-021-02624-0","volume":"473","author":"HK Kim","year":"2021","unstructured":"Kim HK, Seol JE, Ahn SW, Jeon S, Park CS, Han J. Cereblon: promise and challenges for combating human diseases. Pfl\u00fcgers Arch. 2021;473:1\u201317.","journal-title":"Pfl\u00fcgers Arch"},{"key":"3717_CR7","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00424-016-1854-1","volume":"468","author":"HK Kim","year":"2016","unstructured":"Kim HK, Ko TH, Nyamaa B, Lee SR, Kim N, Ko KS, et al. Cereblon in health and disease. Pfl\u00fcgers Arch. 2016;468:1299\u2013309.","journal-title":"Pfl\u00fcgers Arch"},{"key":"3717_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature13527","volume":"512","author":"ES Fischer","year":"2014","unstructured":"Fischer ES, B\u00f6hm K, Lydeard JR, Yang H, Stadler MB, Cavadini S, et al. Structure of the DDB1\u2013CRBN E3 ubiquitin ligase in complex with thalidomide. Nature. 2014;512:49\u201353.","journal-title":"Nature"},{"key":"3717_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1317-7","volume":"10","author":"L Zhou","year":"2019","unstructured":"Zhou L, Xu G. Cereblon attenuates DNA damage-induced apoptosis by regulating the transcription-independent function of p53. Cell Death Dis. 2019;10:69.","journal-title":"Cell Death Dis"},{"key":"3717_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1182\/blood-2014-02-557819","volume":"124","author":"YX Zhu","year":"2014","unstructured":"Zhu YX, Braggio E, Shi CX, Kortuem KM, Bruins LA, Schmidt JE, et al. Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma. Blood. 2014;124:536\u201345.","journal-title":"Blood"},{"key":"3717_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.1177319","volume":"327","author":"T Ito","year":"2010","unstructured":"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, et al. Identification of a primary target of thalidomide teratogenicity. Science. 2010;327:1345\u201350.","journal-title":"Science"},{"key":"3717_CR12","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1038\/leu.2012.119","volume":"26","author":"A Lopez-Girona","year":"2012","unstructured":"Lopez-Girona A, Mendy D, Ito T, Miller K, Gandhi AK, Kang J, et al. Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide. Leukemia. 2012;26:2326\u201335.","journal-title":"Leukemia"},{"key":"3717_CR13","doi-asserted-by":"publisher","first-page":"11395","DOI":"10.1096\/fj.201903060RR","volume":"34","author":"SL Beedie","year":"2020","unstructured":"Beedie SL, Huang PA, Harris EM, Strope JD, Mahony C, Chau CH, et al. Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugs. FASEB J. 2020;34:11395\u2013404.","journal-title":"FASEB J"},{"key":"3717_CR14","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.3389\/fimmu.2019.02203","volume":"10","author":"MJ Kim","year":"2019","unstructured":"Kim MJ, Min Y, Shim JH, Chun E, Lee KY. CRBN is a negative regulator of bactericidal activity and autophagy activation through inhibiting the ubiquitination of ECSIT and BECN1. Front Immunol. 2019;10:2203.","journal-title":"Front Immunol"},{"key":"3717_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1050","volume":"12","author":"MJ Kim","year":"2022","unstructured":"Kim MJ, Lee JS, Kim JY, Choi B, Son J, Min Y, et al. CRBN is downregulated in lung cancer and negatively regulates TLR2, 4 and 7 stimulation in lung cancer cells. Clin Transl Med. 2022;12:e1050.","journal-title":"Clin Transl Med"},{"key":"3717_CR16","doi-asserted-by":"crossref","unstructured":"Shin S, Cho SK. CRBN deletion enhances mitochondrial metabolism by stimulating mitochondrial calcium accumulation in non-small cell lung cancer. Life Sci. 2025;364:123444.","DOI":"10.1016\/j.lfs.2025.123444"},{"key":"3717_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/biof.1624","volume":"46","author":"I Sarfraz","year":"2020","unstructured":"Sarfraz I, Rasul A, Hussain G, Shah MA, Zahoor AF, Asrar M, et al. 6-Phosphogluconate dehydrogenase fuels multiple aspects of cancer cells: From cancer initiation to metastasis and chemoresistance. Biofactors. 2020;46:550\u201362.","journal-title":"Biofactors"},{"key":"3717_CR18","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/ncb3255","volume":"17","author":"R Lin","year":"2015","unstructured":"Lin R, Elf S, Shan C, Kang HB, Ji Q, Zhou L, et al. 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1\u2013AMPK signalling. Nat Cell Biol. 2015;17:1484\u201396.","journal-title":"Nat Cell Biol"},{"key":"3717_CR19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.molcel.2014.06.020","volume":"55","author":"C Shan","year":"2014","unstructured":"Shan C, Elf S, Ji Q, Kang HB, Zhou L, Hitosugi T, et al. Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth. Mol Cell. 2014;55:552\u201365.","journal-title":"Mol Cell"},{"key":"3717_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08921-8","volume":"10","author":"R Liu","year":"2019","unstructured":"Liu R, Li W, Tao B, Wang X, Yang Z, Zhang Y, et al. Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance. Nat Commun. 2019;10:991.","journal-title":"Nat Commun"},{"key":"3717_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbrc.2013.08.048","volume":"439","author":"B Chan","year":"2013","unstructured":"Chan B, VanderLaan PA, Sukhatme VP. 6-Phosphogluconate dehydrogenase regulates tumor cell migration in vitro by regulating receptor tyrosine kinase c-Met. Biochem Biophys Res Commun. 2013;439:247\u201351.","journal-title":"Biochem Biophys Res Commun"},{"key":"3717_CR22","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.molcel.2016.02.032","volume":"61","author":"TV Nguyen","year":"2016","unstructured":"Nguyen TV, Lee JE, Sweredoski MJ, Yang SJ, Jeon SJ, Harrison JS, et al. Glutamine triggers acetylation-dependent degradation of glutamine synthetase via the thalidomide receptor cereblon. Mol Cell. 2016;61:809\u201320.","journal-title":"Mol Cell"},{"key":"3717_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, et al. The ClusPro web server for protein\u2013protein docking. Nat Protoc. 2017;12:255\u201378.","journal-title":"Nat Protoc"},{"key":"3717_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/ct700301q","volume":"4","author":"B Hess","year":"2008","unstructured":"Hess B, Kutzner C, van der Spoel D, Lindahl E. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput. 2008;4:435\u201347.","journal-title":"J Chem Theory Comput"},{"key":"3717_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/bioinformatics\/btq662","volume":"27","author":"P Benkert","year":"2011","unstructured":"Benkert P, Biasini M, Schwede T. Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics. 2011;27:343\u201350.","journal-title":"Bioinformatics"},{"key":"3717_CR26","doi-asserted-by":"publisher","first-page":"W310","DOI":"10.1093\/nar\/gkl206","volume":"34","author":"A Tovchigrechko","year":"2006","unstructured":"Tovchigrechko A, Vakser IA. GRAMM-X public web server for protein\u2013protein docking. Nucleic Acids Res. 2006;34:W310\u20134.","journal-title":"Nucleic Acids Res"},{"key":"3717_CR27","doi-asserted-by":"publisher","first-page":"W229","DOI":"10.1093\/nar\/gkn186","volume":"36","author":"E Mashiach","year":"2008","unstructured":"Mashiach E, Schneidman-Duhovny D, Andrusier N, Nussinov R, Wolfson HJ. FireDock: a web server for fast interaction refinement in molecular docking. Nucleic Acids Res. 2008;36:W229\u201332.","journal-title":"Nucleic Acids Res"},{"key":"3717_CR28","doi-asserted-by":"publisher","first-page":"W382","DOI":"10.1093\/nar\/gki387","volume":"33","author":"J Schymkowitz","year":"2005","unstructured":"Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, Serrano L. The FoldX web server: an online force field. Nucleic Acids Res. 2005;33:W382\u20138.","journal-title":"Nucleic Acids Res"},{"key":"3717_CR29","doi-asserted-by":"publisher","first-page":"pl2","DOI":"10.1126\/stke.2192004pl2","volume":"2004","author":"T Kortemme","year":"2004","unstructured":"Kortemme T, Kim DE, Baker D. Computational alanine scanning of protein-protein interfaces. Sci STKE. 2004;2004:pl2.","journal-title":"Sci STKE"},{"key":"3717_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/bioinformatics\/19.1.163","volume":"19","author":"F Glaser","year":"2003","unstructured":"Glaser F, Pupko T, Paz I, Bell RE, Bechor-Shental D, Martz E, et al. ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics. 2003;19:163\u20134.","journal-title":"Bioinformatics"},{"key":"3717_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56177-5","volume":"9","author":"K Kim","year":"2019","unstructured":"Kim K, Lee DH, Park S, Jo SH, Ku B, Park SG, et al. Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera. Sci Rep. 2019;9:19654.","journal-title":"Sci Rep"},{"key":"3717_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.811044","volume":"10","author":"L Wang","year":"2022","unstructured":"Wang L, Lu B, He M, Wang Y, Wang Z, Du L. Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front Public Health. 2022;10:811044.","journal-title":"Front Public Health"},{"key":"3717_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","volume":"87","author":"EJ Schafer","year":"2025","unstructured":"Schafer EJ, Laversanne M, Sung H, Soerjomataram I, Briganti A, Dahut W, et al. Recent patterns and trends in global prostate cancer incidence and mortality: an update. Eur Urol. 2025;87:302\u201313.","journal-title":"Eur Urol"},{"key":"3717_CR34","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3717_CR35","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","volume":"367","author":"HI Scher","year":"2012","unstructured":"Scher HI, Fizazi K, Saad F, Taplin ME, Sternberg CN, Miller K, et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med. 2012;367:1187\u201397.","journal-title":"N Engl J Med"},{"key":"3717_CR36","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","volume":"364","author":"JS de Bono","year":"2011","unstructured":"de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, et al. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med. 2011;364:1995\u20132005.","journal-title":"N Engl J Med"},{"key":"3717_CR37","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/0006-291X(72)90672-9","volume":"48","author":"M Rippa","year":"1972","unstructured":"Rippa M, Signorini M, Dallocchio F. Differentiation between the structural and redox roles of TPNH in 6-phosphogluconate dehydrogenase. Biochem Biophys Res Commun. 1972;48:764\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"3717_CR38","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1016\/S0021-9258(19)43652-1","volume":"248","author":"M Rippa","year":"1973","unstructured":"Rippa M, Signorini M, Dallocchio F. A multiple role for the coenzyme in the mechanism of action of 6-phosphogluconate dehydrogenase: the oxidative decarboxylation of 2-deoxy-6-phosphogluconate. J Biol Chem. 1973;248:4920\u20135.","journal-title":"J Biol Chem"},{"key":"3717_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo0404","volume":"8","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Xu Y, Lu W, Li J, Yu S, Brown EJ, et al. G6PD-mediated increase in de novo NADP+ biosynthesis promotes antioxidant defense and tumor metastasis. Sci Adv. 2022;8:eabo0404.","journal-title":"Sci Adv"},{"key":"3717_CR40","doi-asserted-by":"publisher","first-page":"110650","DOI":"10.1016\/j.celrep.2022.110607","volume":"39","author":"C Chen","year":"2022","unstructured":"Chen C, Lai X, Zhang Y, Xie L, Yu Z, Dan S, et al. NADPH metabolism determines the leukemogenic capacity and drug resistance of AML cells. Cell Rep. 2022;39:110650.","journal-title":"Cell Rep"},{"key":"3717_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102627","volume":"61","author":"D Ilter","year":"2023","unstructured":"Ilter D, Drapela S, Schild T, Ward NP, Adhikari E, Low V, et al. NADK-mediated de novo NADP(H) synthesis is a metabolic adaptation essential for breast cancer metastasis. Redox Biol. 2023;61:102627.","journal-title":"Redox Biol"},{"key":"3717_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101685","volume":"36","author":"C Shao","year":"2020","unstructured":"Shao C, Lu W, Du Y, Yan W, Bao Q, Tian Y, et al. Cytosolic ME1 integrated with mitochondrial IDH2 supports tumor growth and metastasis. Redox Biol. 2020;36:101685.","journal-title":"Redox Biol"},{"key":"3717_CR43","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.62592","volume":"10","author":"JL Gillis","year":"2021","unstructured":"Gillis JL, Hinneh JA, Ryan NK, Irani S, Moldovan M, Quek LE, et al. A feedback loop between the androgen receptor and 6-phosphogluconate dehydrogenase (6PGD) drives prostate cancer growth. eLife. 2021;10:e62586.","journal-title":"eLife"},{"key":"3717_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nature16979","volume":"532","author":"G Petzold","year":"2016","unstructured":"Petzold G, Fischer ES, Thom\u00e4 NH. Structural basis of lenalidomide-induced CK1\u03b1 degradation by the CRL4CRBN ubiquitin ligase. Nature. 2016;532:127\u201330.","journal-title":"Nature"},{"key":"3717_CR45","doi-asserted-by":"crossref","unstructured":"Crowell PD, Giafaglione JM, Jones AE, Nunley NM, Hashimoto T, Delcourt AM, et al. MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer. Cell Rep. 2023;42:113221.","DOI":"10.1016\/j.celrep.2023.113221"},{"key":"3717_CR46","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1038\/emboj.2011.158","volume":"30","author":"CE Massie","year":"2011","unstructured":"Massie CE, Lynch A, Ramos-Montoya A, Boren J, Stark R, Fazli L, et al. The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J. 2011;30:2719\u201333.","journal-title":"EMBO J"},{"key":"3717_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118729","volume":"1867","author":"SJ Yang","year":"2020","unstructured":"Yang SJ, Jeon SJ, Van Nguyen T, Deshaies RJ, Park CS, Lee KM. Ubiquitin-dependent proteasomal degradation of AMPK gamma subunit by Cereblon inhibits AMPK activity. Biochimica et Biophysica Acta (BBA)-Mol Cell Res. 2020;1867:118729.","journal-title":"Biochimica et Biophysica Acta (BBA)-Mol Cell Res"},{"key":"3717_CR48","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/ph14060512","volume":"14","author":"SJ Yang","year":"2021","unstructured":"Yang SJ, Jeon S, Baek JW, Lee KM, Park CS. Regulation of AMPK activity by CRBN is independent of the thalidomide-CRL4CRBN protein degradation axis. Pharmaceuticals. 2021;14:512.","journal-title":"Pharmaceuticals"},{"key":"3717_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19272-0","volume":"11","author":"H Moon","year":"2020","unstructured":"Moon H, Min C, Kim G, Kim D, Kim K, Lee SA, et al. Crbn modulates calcium influx by regulating Orai1 during efferocytosis. Nat Commun. 2020;11:5489.","journal-title":"Nat Commun"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03717-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03717-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03717-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T22:02:07Z","timestamp":1774821727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03717-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":49,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,4,18]]}},"alternative-id":["3717"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03717-9","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal experiments in this study were approved by the Institutional Animal Care and Use Committee of Asan Institute for Life Sciences (Approval number 2020-13-195) and Inha University, Korea.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}},{"value":"All authors approved for the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}